Asthma - chronic inflammatory condition that characterised by reversible airway limitation (obstruction), hyperresponsiveness to wide range of stimuli and inflammation of bronchi cause smooth muscle hyperthrophy, mucus plugging and epithelial damage.
COPD - chonic inflammatroy progressive irrevesible airway limitation. Related to ephysema and chronic bronchitis.
2. Cx and examination.
SOB, cough,fever (+-)
COAD: smoking hx, hyperinflated lung
asthma:
- symptops: SOB, cough, fever (+,-)
- history of asthma
- duration
- elimination of other DDX
- precipitating factor (emotion, cold, dusk, exercise, URTI, chemical) and occupation
- assess current severity
- assess severity of asthma ( freq, noctunal, daytime sym, use of B-agonist inhaler, PEFM)
- QOL
- Mhx: eczema, asthma, urticaria, allergic rhinitis.
- family history of asthma
- social : smoking
4. Differential diagnosis for SOB
- MI
- pneumotorax
- pulmonary embolism
- respiratory infection
- anxiety
- COPD
- metabolic acidosis
3. Complication
COPD: Respiratory failure and cor pulmonale (heart dz secodary to respiratory dz)
4. Investigation
diagnostic: CXR (to exclude pneumotorax), ECG , FBC
assess severity: Peak flow meter, lung spirometry, ABG
5. Management
ASTHMA
aim:
Management:
Aims of treatment:
Management:
Aims of treatment:
Abolish symptoms
Restore normal and best possible lung function
Reduce the risk of severe attacks
Enable normal growth to occur in children
Minimize absence from school employment
This involves:
Patient and family education about asthma
Patient and family participation in treatment
Avoidance of identified causes where possible
Use of the lowest effective doses of convenient medication to minimize short-term and long-term side effects
Control of extrinsic factors
- Avoid causative allergens: house dust mite, pets, moulds
- Active and passive smoking
- Avoid Beta blockers in tablet or eye drop form
- Avoid NSAIDS
- Avoid exposed to materials at works
DRUG.
Asthma self-management: Peak flow meters, treatment plans discussed with each patient
-An inflammatory disease + Anti-inflammatory
controller therapy started even in mild cases
-Inhaled oral steroids
-Short-acting relievers: Salbutamol, Terbutaline
-Long-acting relief/ disease controllers
*Long-acting β2 agonists: Salmeterol, Formoterol
*Sodium Cromoglycate
*Leukotriene Modifiers: Montelukast, Zafirlukast
-Other agent with bronchodilator activity
*Antimuscarinic agents: Ipratratropium, Oxitropium
*Theophylline preparations
-Steroid sparing agents: Methotrexate, Ciclosporin,
Gold, IV Ig, Anti-IgE monoclonal antibody
omalizumab.
Acute Mx:
specific treatment:
COPD
Acute Mx:
specific treatment:
1) Counseling
2) Reduce risk factors
3) Manage stable COPD
4) Manage exacerbations
5) Manage complications
6.THERAPUTIC
to be continued
No comments:
Post a Comment